Tretinoin tocoferil

Drug Profile

Tretinoin tocoferil

Alternative Names: L 300; N 021; N 021G; Olcenon; Tocoretinate

Latest Information Update: 20 Oct 2009

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nisshin Pharma
  • Class Antiulcers; Retinoids; Small molecules
  • Mechanism of Action Antioxidants; Free radical scavengers; Retinoic acid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Skin ulcer
  • Suspended Peptic ulcer

Most Recent Events

  • 16 Oct 2009 Wyeth has been acquired by Pfizer
  • 11 Sep 2000 Suspended-Phase Unspecified in Peptic ulcer in Japan (PO)
  • 17 Jul 1998 No-Development-Reported for Peptic ulcer in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top